Cited by 8,029Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Open access

The SOLVD Investigators*·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250501

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. METHODS: Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-bind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. RESULTS: There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P less than 0.0001). CONCLUSIONS: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250501

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A. N., Devereux, R. B., Feigenbaum, H., Gutgesell, H. P., Reichek, N., Sahn, D. J., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,110
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386

Show all 15 references

Research works printed but not linked: 1

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

Sorted by citations

Items 901–1,000 of 1,027

Aldosteronism and Peripheral Blood Mononuclear Cell Activation
Ahokas, R. A., Warrington, K. J., Gerling, I., Sun, Y., Wodi, L. A., Herring, P. A., Lu, L., Bhattacharya, S. K., Postlethwaite, A. E., & Weber, K. T. (2003) · Circulation Research · doi:10.1161/01.res.0000102404.81461.25 · Cited by 128
Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial.
Hohnloser, S. H., Franck, P., Klingenheben, T., Zabel, M., & Just, H. (1994) · Circulation · doi:10.1161/01.cir.90.4.1747 · Cited by 128
Cardiovascular Disease in Adult Survivors of Childhood Cancer
Lipshultz, S. E., Franco, V. I., Miller, T. L., Colan, S. D., & Sallan, S. E. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-070213-054849 · Cited by 127
Signalment, Survival, and Prognostic Factors in Doberman Pinschers With End-Stage Cardiomyopathy
Calvert, C. A., Pickus, C. W., Jacobs, G. J., & Brown, J. (1997) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1997.tb00474.x · Cited by 127
Casein Hydrolysate Containing the Antihypertensive Tripeptides Val-Pro-Pro and Ile-Pro-Pro Improves Vascular Endothelial Function Independent of Blood Pressure-Lowering Effects: Contribution of the Inhibitory Action of Angiotensin-Converting Enzyme
Hirota, T., Ohki, K., Kawagishi, R., Kajimoto, Y., Mizuno, S., Nakamura, Y., & Kitakaze, M. (2007) · Hypertension Research · doi:10.1291/hypres.30.489 · Cited by 127
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension
Laragh, J. H. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01301-7 · Cited by 127
North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care
Eccles, M., Freemantle, N., & Mason, J. M. (1998) · BMJ · doi:10.1136/bmj.316.7139.1232 · Cited by 127
Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol
Lenarda, A. D., Sabbadini, G., Salvatore, L., Sinagra, G., Mestroni, L., Pinamonti, B., Gregori, D., Ciani, F., Muzzi, A., Klugmann, S., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00134-5 · Cited by 127
Reinventing the ACE inhibitors: some old and new implications of ACE inhibition
Hanif, K., Bid, H. K., & Konwar, R. (2009) · Hypertension Research · doi:10.1038/hr.2009.184 · Cited by 126
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
Ferrario, C. M., & Mullick, A. E. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.020 · Cited by 126
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA ( Vericiguat Global Study in Subjects with HFrEF ) trial
Voors, A. A., Mulder, H. S., Reyes, E. B., Cowie, M., Lassus, J. P. E., Hernandez, A. F., Ezekowitz, J. A., Butler, J., O’Connor, C. M., Koglin, J., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2221 · Cited by 126
Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial Infarction: A Class Effect?
Pilote, L., Abrahamowicz, M., Rodrigues, E., Eisenberg, M. J., & Rahme, E. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-2-200407200-00008 · Cited by 126
Chronic kidney disease and heart failure—Bidirectional close link and common therapeutic goal
Shiba, N., & Shimokawa, H. (2010) · Journal of Cardiology · doi:10.1016/j.jjcc.2010.09.004 · Cited by 125
Epidemiology of Heart Failure with Preserved Ejection Fraction
Dhingra, A., Garg, A., Kaur, S., Chopra, S., Batra, J. S., Pandey, A., Chaanine, A. H., & Agarwal, S. K. (2014) · Current Heart Failure Reports · doi:10.1007/s11897-014-0223-7 · Cited by 125
Neprilysin Inhibition to Treat Heart Failure: A Tale of Science, Serendipity, and Second Chances
McMurray, J. J. V. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.250 · Cited by 125
Cardiac remodelling and RAS inhibition
Ferrario, C. M. (2016) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944716642677 · Cited by 125
The role of endothelins and their receptors in heart failure
Giannessi, D., Ry, S. D., & Vitale, R. L. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0758 · Cited by 125
Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure
Zugck, C., Haunstetter, A., Krüger, C., Kell, R., Schellberg, D., Kübler, W., & Haass, M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01840-5 · Cited by 125
Tissue renin angiotensin systems
Ré, R. N. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00124-x · Cited by 125
Strategies to achieve coronary arterial plaque stabilization
Rabbani, R. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00279-x · Cited by 125
Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals
Philbin, E. F., Andreou, C., Rocco, T. A., Lynch, L. J., & Baker, S. L. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89177-1 · Cited by 125
Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
Fairweather, D., Beetler, D. J., Musigk, N., Heidecker, B., Lyle, M. A., Cooper, L. T., & Bruno, K. A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1129348 · Cited by 124
Phosphodiesterase III inhibitors for heart failure
Amsallem, E., Kasparian, C., Haddour, G., Boissel, J., & Nony, P. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002230.pub2 · Cited by 124
Epidemiology, Pathophysiology, Prognosis, and Treatment of Systolic and Diastolic Heart Failure
Aronow, W. S. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000175289.87583.e5 · Cited by 124
Collagen Scar Formation After Acute Myocardial Infarction
Uusimaa, P., Risteli, J., Niemelä, M. J., Lumme, J., Ikäheimo, M. J., Jounela, A. J., & PEUHKURINEN, K. J. (1997) · Circulation · doi:10.1161/01.cir.96.8.2565 · Cited by 124
Clinical Pharmacokinetics and Selective Pharmacodynamics of New Angiotensin Converting Enzyme Inhibitors
Song, J., & White, C. M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241030-00005 · Cited by 124
Angiotensin-Converting Enzyme Inhibitors
Izzo, J. L., & Weir, M. R. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00508.x · Cited by 124
SLEEP APNEA IN CONGESTIVE HEART FAILURE
Naughton, M. T., & Bradley, T. D. (1998) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70435-4 · Cited by 124
Vital epidemiologic clues in heart failure
Kannel, W. B. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00135-3 · Cited by 124
Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background Therapy
Okumura, N., Jhund, P. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Swedberg, K. B., Zile, M. R., Solomon, S. D., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.116.003212 · Cited by 123
The Incidence of Ischemic Stroke in Chronic Heart Failure: A Meta-Analysis
Witt, B. J., Gami, A. S., Ballman, K. V., Brown, R. D., Meverden, R. A., Jacobsen, S. J., & Roger, V. L. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.01.009 · Cited by 123
Prognostic value of serum cytokines in patients with congestive heart failure
Orús, J., Roig, E. S., Pérez‐Villa, F., Paré, C., Azqueta, M., Filella, X., Heras, M., & Sanz, G. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00083-8 · Cited by 123
A Review of Quality-of-Life Evaluations in Patients with Congestive Heart Failure
Berry, C., & McMurray, J. J. V. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916030-00003 · Cited by 123
MicroRNAs in Heart Failure
Melman, Y. F., Shah, R. V., & Das, S. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000266 · Cited by 122
AMPK: a therapeutic target of heart failure—not only metabolism regulation
Li, X., Liu, J., Lü, Q., Ren, D., Sun, X., Rousselle, T. V., Tan, Y., & Li, J. (2018) · Bioscience Reports · doi:10.1042/bsr20181767 · Cited by 122
Edema formation in congestive heart failure and the underlying mechanisms
Abassi, Z. A., Khoury, E. E., Karram, T., & Aronson, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.933215 · Cited by 122
Alterations in Cardiac Structure and Function in Hypertension
Santos, M., & Shah, A. M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0428-x · Cited by 122
Angiotensin II formation in the intact human heart. Predominance of the angiotensin-converting enzyme pathway.
Zisman, L. S., Abraham, W. T., Meixell, G. E., Vamvakias, B. N., Quaife, R. A., Lowes, B. D., Roden, R. L., Peacock, S. J., Groves, B. Μ., & Raynolds, M. V. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118186 · Cited by 122
The past, present and future of renin–angiotensin aldosterone system inhibition
Mentz, R. J., Bakris, G. L., Waeber, B., McMurray, J. J. V., Gheorghiade, M., Ruilope, L. M., Maggioni, A. P., Swedberg, K. B., Piña, I. L., Fiuzat, M., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.007 · Cited by 121
Acute Effects of Continuous Positive Airway Pressure on Cardiac Sympathetic Tone in Congestive Heart Failure
Kaye, D. M., Mansfield, D. R., Aggarwal, A., Naughton, M. T., & Esler, M. (2001) · Circulation · doi:10.1161/01.cir.103.19.2336 · Cited by 121
Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure
Chin, M. H., Friedmann, P. D., Cassel, C. K., & Lang, R. M. (1997) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1997.07105.x · Cited by 121
Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.
Wollert, K. C., Studer, R., von Bülow, B., & Drexler, H. (1994) · Circulation · doi:10.1161/01.cir.90.5.2457 · Cited by 121
The cardiovascular dysmetabolic syndrome
Fagan, T. C., & DEEDWANIA, P. C. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00216-2 · Cited by 121
Effects of ACE-Inhibitors and Angiotensin Receptor Blockers on Inflammation
Raimondo, D. D., Tuttolomondo, A., Buttà, C., Miceli, S., Licata, G., & Pinto, A. V. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802481282 · Cited by 120
How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?
Svensson, M., Gustafsson, F., Galatius, S., Hildebrandt, P. R., & Atar, D. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2003.10.012 · Cited by 120
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors
Granger, C. B., Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Investigators, Ertl, G., Kuch, J., Maggioni, A. P., McMurray, J. J. V., Rouleau, J. L., Stevenson, L. W., Swedberg, K. B., Young, J. B., et al. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90037-1 · Cited by 120
Guidelines for the Management of Hypertension for General Practitioners.
Japanese Society of Hypertension Gu (2001) · Hypertension Research · doi:10.1291/hypres.24.613 · Cited by 120
The Efficacy and Safety of Crataegus Extract WS® 1442 in Patients with Heart Failure: The SPICE Trial
Holubarsch, C., Colucci, W. S., Meinertz, T., Gaus, W., Tendera, M., & Survival and Prognosis: Investigation of Crataegus Extract WS® 1442 in CHF (SPICE) trial study group (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.10.004 · Cited by 119
Clinical Characteristics and Prognosis of Hospitalized Patients With Congestive Heart Failure
Tsuchihashi, M., Tsutsui, H., Kodama, K., Kasagi, F., & Takeshita, A. (2000) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.64.953 · Cited by 119
Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction
Cooper, H. A., Exner, D. V., & DOMANSKI, M. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00625-2 · Cited by 119
Cardiomyocyte apoptosis in the failing heart — A critical review from definition and classification of cell death
Takemura, G., Kanoh, M., Minatoguchi, S., & Fujiwara, H. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.01.163 · Cited by 118
The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines
Bell, A., Roussin, A., Cartier, R., Chan, W., Douketis, J. D., Gupta, A. K., Kraw, M. E., Lindsay, T. F., Love, M. P., Pannu, N., et al. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.015 · Cited by 118
Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block
Sze, E. Y., Samad, Z. Z., Dunning, A. L., Campbell, K. B., Loring, Z., Atwater, B. D., Chiswell, K., KISSLO, J. A., Velazquez, E. J., & Daubert, J. P. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.020 · Cited by 118
Left Atrial Function Predicts Cardiovascular Events in Patients With Chronic Heart Failure With Reduced Ejection Fraction
Malagoli, A., Rossi, L. C., Bursi, F., Zanni, A., Sticozzi, C., Piepoli, M. F., & VILLANI, G. Q. (2018) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2018.08.012 · Cited by 118
Practical applications in stress echocardiography
Yao, S., Qureshi, E. A., Sherrid, M. V., & Chaudhry, F. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00923-9 · Cited by 118
Repeated Sauna Therapy Increases Arterial Endothelial Nitric Oxide Synthase Expression and Nitric Oxide Production in Cardiomyopathic Hamsters
Ikeda, Y., Biro, S., Kamogawa, Y., Yoshifuku, S., Eto, H., Orihara, K., Yu, B., Kihara, T., Miyata, M., Hamasaki, S., et al. (2005) · Circulation Journal · doi:10.1253/circj.69.722 · Cited by 118
Prevalence of Preclinical and Clinical Heart Failure in the Elderly. A Population-Based Study in Central Italy
Mureddu, G. F., Agabiti, N., Rizzello, V., Forastiere, F., Latini, R., Cesaroni, G., Masson, S., Cacciatore, G., Colivicchi, F., Uguccioni, M., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs052 · Cited by 118
Gender Differences in the Pathophysiology, Clinical Presentation, and Outcomes of Ischemic Heart Failure
Dunlay, S. M., & Roger, V. L. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0107-7 · Cited by 118
Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: An analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B., O’Connor, C. M., Sun, J. L., Yancy, C. W., & Young, J. B. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.10.008 · Cited by 118
Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial
Smith, L., Vennelle, M., Gardner, R. S., McDonagh, T. A., Denvir, M. A., Douglas, N. J., & Newby, D. E. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm131 · Cited by 118
Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients
Nony, P., Boissel, J., Lièvre, M., Leizorovicz, A., Haugh, M. C., Fareh, S., & Breyne, B. D. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00192547 · Cited by 118
Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure?
Stenvinkel, P., Andersson, P., Wang, T., Lindholm, B., Bergström, J. P., Palmblad, J. E. W., Heimbürger, O., & Cederholm, T. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00560.x · Cited by 118
Heart failure clinics and outpatient management: review of the evidence and call for quality assurance
Gustafsson, F., & ARNOLD, J. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.023 · Cited by 118
Cardiac Angiotensin II Receptors Are Upregulated by Long-Term Inhibition of Nitric Oxide Synthesis in Rats
Katoh, M., Egashira, K., Usui, M., Ichiki, T., Tomita, H., Shimokawa, H., Rakugi, H., & Takeshita, A. (1998) · Circulation Research · doi:10.1161/01.res.83.7.743 · Cited by 118
Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts.
Schorb, W., Peeler, T. C., Madigan, N. N., Conrad, K., & Baker, K. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32215-9 · Cited by 118
Effect of Oral Digoxin in High-Risk Heart Failure Patients: A Pre-Specified Subgroup Analysis of the DIG Trial
Gheorghiade, M., Patel, K., Filippatos, G. S., Anker, S. D., van Veldhuisen, D. J., Cleland, J. G. F., Metra, M., Aban, I., Greene, S. J., Adams, K. F., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft010 · Cited by 117
Advanced Heart Failure
Chaudhry, S., & Stewart, G. C. (2016) · Heart Failure Clinics · doi:10.1016/j.hfc.2016.03.001 · Cited by 117
Update on heart failure management and future directions
Choi, H., Park, M., & Youn, J. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.428 · Cited by 117
Management of Heart Failure Patient with CKD
Banerjee, D., Rosano, G., & Herzog, C. A. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.14180920 · Cited by 117
Anti-Remodelling Effect of Canrenone in Patients with Mild Chronic Heart Failure (AREA IN-CHF study): Final Results
Boccanelli, A., Mureddu, G. F., Cacciatore, G., Clemenza, F., Lenarda, A. D., Gavazzi, A., Porcu, M., Latini, R., Lucci, D., Maggioni, A. P., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn015 · Cited by 117
Cardiac troponins in congestive heart failure
Carlo, C. H. D., & O’Connor, C. M. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70178-x · Cited by 117
Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure
Goussev, A., Sharov, V. G., Shimoyama, H., Tanimura, M., Lesch, M., Goldstein, S., & Sabbah, H. N. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.2.h626 · Cited by 117
Incremental Prognostic Value of Myocardial Fibrosis in Patients With Non–Ischemic Cardiomyopathy Without Congestive Heart Failure
Masci, P. G., Doulaptsis, C., Bertella, E., Torto, A. D., Symons, R., Pontone, G., Barison, A., Droogné, W., Andreini, D., Lorenzoni, V., et al. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000996 · Cited by 116
Renin-Angiotensin System and Atherothrombotic Disease
Jacoby, D. S., & Rader, D. J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.10.1155 · Cited by 116
Why Are Physicians Not Prescribing Diuretics More Frequently in the Management of Hypertension?
Moser, M. (1998) · JAMA · doi:10.1001/jama.279.22.1813 · Cited by 116
Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia
Stellbrink, C., Auricchio, A., Diem, B., Breithardt, O. A., Kloss, M., Schöndube, F. A., Klein, H., Messmer, B. J., & Hanrath, P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)01016-9 · Cited by 116
The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: Results of the REVERSE study
Gold, M. R., Daubert, J., Abraham, W. T., Ghio, S., Sutton, M. S. J., Hudnall, J. H., Cerkvenik, J., & Linde, C. M. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.11.014 · Cited by 115
Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS)
Everitt, M. D., Donaldson, A. E., Stehlik, J., Kaza, A. K., Budge, D., Alharethi, R. A., Bullock, E. A., Kfoury, A. G., & Yetman, A. T. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.09.008 · Cited by 115
Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population
Chia, Y. C., Kieneker, L. M., van Hassel, G., Binnenmars, S. H., Nolte, I. M., van Zanden, J. J., van der Meer, P., Navis, G. J., Voors, A. A., Bakker, S. J. L., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018549 · Cited by 115
Right Ventricular Performance and Contractile Reserve in Patients With Severe Heart Failure
Gorcsan, J., Murali, S., Counihan, P. J., Mandarino, W. A., & Kormos, R. L. (1996) · Circulation · doi:10.1161/01.cir.94.12.3190 · Cited by 115
Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction
Soejima, H., Ogawa, H., Yasue, H., Kaikita, K., Takazoe, K., Nishiyama, K., Misumi, K., Miyamoto, S., Yoshimura, M., Kugiyama, K., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00318-6 · Cited by 115
Survival with oral d-Sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial)
Waldo, A. L., CAMM, A. J., deRuyter, H., Friedman, P. L., MacNeil, D. J., Pitt, B., Pratt, C. M., Rodda, B. E., Schwartz, P. J., & The SWORD Investigators (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80717-6 · Cited by 115
Self-citation
RAS inhibition in hypertension
Ibrahim, M. M. (2006) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001960 · Cited by 114
Prognosis of Individuals With Asymptomatic Left Ventricular Systolic Dysfunction in the Multi-Ethnic Study of Atherosclerosis (MESA)
Yeboah, J., Rodríguez, C. J., Stacey, B. R., Lima, J. A. C., Liu, S., Carr, J. J., Hundley, W. G., & Herrington, D. M. (2012) · Circulation · doi:10.1161/circulationaha.112.112201 · Cited by 114
Long-term chemotherapy-related cardiovascular morbidity
Meinardi, M. T., Gietema, J. A., van Veldhuisen, D. J., van der Graaf, W. T. A., de Vries, E. G. E., & Sleijfer, D. T. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0175 · Cited by 114
Pathobiology of Left Ventricular Dyssynchrony and Resynchronization
SPRAGG, D. D., & Kass, D. A. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.05.001 · Cited by 114
Clinical Use of Inotropic Therapy for Heart Failure: Looking Backward or Forward? Part I: Inotropic Infusions During Hospitalization
Stevenson, L. W. (2003) · Circulation · doi:10.1161/01.cir.0000078348.44634.ba · Cited by 114
1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH Meeting.
Mashiba, H., Zanchetti, A., Chalmers, J. P., Arakawa, K., Gyarfas, I., Hamet, P., Hansson, L., Julius, S., MacMahon, S. W., Mancia, G., et al. (1993) · Hypertension Research · doi:10.1291/hypres.16.149 · Cited by 114
Clinical characteristics of patients in Studies of Left Ventricular Dysfunction (SOLVD)
Johnstone, D. E., Limacher, M. C., Rousseau, M. F., Liang, C., Ekelund, L. G., Herman, M. V., Stewart, D. K., Guillotte, M., Bjerken, G., Gaasch, W. H., et al. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90734-g · Cited by 114
Self-citation
Canine Ventricular Myocytes Possess a Renin-Angiotensin System That Is Upregulated With Heart Failure
Barlucchi, L., Leri, A., Dostal, D. E., Fiordaliso, F., Tada, H., Hintze, T. H., Kajstura, J., Nadal‐Ginard, B., & Anversa, P. (2001) · Circulation Research · doi:10.1161/01.res.88.3.298 · Cited by 114
Angiotensin II receptor antagonists: A new approach to blockade of the renin-angiotensin system
Kang, P. M., Landau, A. J., Eberhardt, R. T., & Frishman, W. H. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90061-2 · Cited by 114
Left Ventricular Systolic Dysfunction, Total Mortality, and Sudden Death in Patients with Myocardial Infarction Treated with n-3 Polyunsaturated Fatty Acids
Macchia, A., Levantesi, G., Franzosi, M. G., Geraci, E., Maggioni, A. P., Marfisi, R., Nicolosi, G. L., Schweiger, C., Tavazzi, L., Tognoni, G., et al. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.04.008 · Cited by 113
Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors at Risk for Treatment-Related Heart Failure
Wong, F. L., Bhatia, R., Landier, W., Francisco, L., Leisenring, W. M., Hudson, M. M., Armstrong, G. T., Mertens, A. C., Stovall, M., Robison, L. L., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2498 · Cited by 113
Diagnosis of heart failure in primary care
Fonseca, C. (2006) · Heart Failure Reviews · doi:10.1007/s10741-006-9481-0 · Cited by 113
Drug-induced heart failure
Feenstra, J., Grobbee, D. E., Remme, W. J., & Stricker, B. H. C. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00006-6 · Cited by 113
Association between renin–angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study
Edner, M., Benson, L., Dahlström, U., & Lund, L. H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv268 · Cited by 113
Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005)
de Diagnóstico, G. D. T., & de Cardiología, T. D. L. I. C. C. D. L. S. E. (2005) · Revista Española de Cardiología · doi:10.1157/13078554 · Cited by 113
Left Ventricular Assist Devices
Stevenson, L. W., & Rose, E. A. (2003) · Circulation · doi:10.1161/01.cir.0000090961.53902.99 · Cited by 113
Implantable Left Ventricular Assist Devices Provide an Excellent Outpatient Bridge to Transplantation and Recovery
DeRose, J. J., Umana, J. P., Argenziano, M., Catanese, K. A., Gardocki, M. T., Flannery, M. A., Levin, H. R., Sun, B., Rose, E. A., & Oz, M. C. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00396-3 · Cited by 113
Doxorubicin‐Induced Cardiomyopathy in Children
Mancilla, T. R., Iskra, B., & Aune, G. J. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180017 · Cited by 108

Authors: The SOLVD Investigators*
Corresponding author: The SOLVD Investigators*
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 293-302
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250501
OpenAlex: W2585382523
Cited by: 8,029
References: 15
Citations by year: 2026: 78 · 2025: 89 · 2024: 117 · 2023: 152 · 2022: 174 · 2021: 167 · 2020: 182 · 2019: 174 · 2018: 174 · 2017: 187 · 2016: 211 · 2015: 208 · 2014: 165 · 2013: 168 · 2012: 231
FWCI: 170.62
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, ACE inhibitors, congestive heart failure, reduced left ventricular ejection fraction, mortality, hospitalization, heart failure progression, cardiac arrhythmias, NYHA functional class
MeSH terms: Blood Pressure, Cause of Death, Chronic Disease, Double-Blind Method, Electrolytes, Enalapril, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Kidney, Male, Middle Aged, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks